Using a dual luciferase 3′ UTR reporter assay, we verified that miR-221/222 facilitates pancreatic cancer invasion by directly targeting TIMP-2, which is an inhibitor of MMPs. The gene discussed is TIMP2; the disease is pancreatic neoplasm.